ArticleJPGN reports2026
The genetic landscape of congenital diarrheas and very early onset inflammatory bowel disease in the Middle East.
Article in JPGN reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Monogenic causes of congenital diarrheas and enteropathies (CoDE) and very early onset inflammatory bowel disease (VEOIBD) are mostly recessive and therefore more prevalent in populations with increased consanguinity rates. To assess the genetic basis of these disorders in a likely high-prevalence population, we established a multi-center cohort of patients across the Middle East. Methods: Patients were enrolled across four centers in the Middle East. Clinical data, including self-reported consanguinity, were collected. Trio whole exome sequencing (WES) was performed, and genomic data were processed through a standardized variant identification pipeline. Patients who inherited a rare variant consistent with the disease in a gene known to be causative for CoDE or VEOIBD were classified as having a monogenic etiology. Self-reported consanguinity and homozygosity mapping were analyzed and correlated with monogenic diagnoses. Results: WES from trios of 27 patients (13 CoDE and 14 VEOIBD) were analyzed. Higher frequency of consanguinity was self-reported by the CoDE families (11/13, 84.6%) and confirmed by homozygosity mapping than in the VEOIBD group (4/14, 28.6%). A monogenic cause of disease was identified in 10 of 13 CoDE patients (76.9%) in the following genes: Conclusions: Within this limited cohort, the diagnostic yield for known genes associated with CoDE was high, consistent with the primarily monogenic etiology and high consanguinity. For VEOIBD, the diagnostic yield was lower and similar to that reported in North America.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.